Article Information
History
- May 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Manel Essaidi-Laziosi1,‡,
- Francisco Javier Perez Rodriguez2,
- Pascale Sattonnet-Roche2,
- Nicolas Hulo3,
- Frederique Jacquerioz2,
- Laurent Kaiser2 and
- Isabella Eckerle1,2,†
- 1Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland
- 2Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland
- 3Service for Biomathematical and Biostatistical Analyses. Institute of Genetics and Genomics, University of Geneva, Geneva, Switzerland
- ↵†Corresponding author: Isabella Eckerle, Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. Tel: +41223729820; FAX: +41223724097; Email: isabella.eckerle{at}unige.ch
- ↵‡Alternate corresponding author. Manel Essaidi-Laziosi, Department of Microbiology and Molecular Medicine, Faculty of Medicine of Geneva, University of Geneva, Geneva, Switzerland. Rue Michel-Servet 1, 1205 Geneva. Tel. +41223795528, Email: Manel.Essaidi{at}unige.ch
Posted May 19, 2021.
Assessment of the infectious threshold of SARS-CoV-2 in primary airway epithelial cells
